10.1016/j.ejmech.2007.04.017
The study focuses on the synthesis and characterization of Cu(II), Fe(III), and Mn(II) complexes of a novel ligand, N-[(4-methoxy)thiobenzoyl]benzoic acid hydrazide (H2mtbh), and evaluates their bioactivity, particularly their cytotoxic effects on HT29 colon cancer cells and their ability to inhibit N-myristoyltransferase (NMT) activity. The chemicals used include the metal salts CuCl2$2H2O, Cu(OAc)2$H2O, Mn(OAc)2$4H2O, and Fe(acac)3, which react with H2mtbh to form the respective metal complexes. These complexes serve to investigate their potential as anticancer agents, with the aim of finding new drugs with different modes of action compared to existing chemotherapeutic drugs like cisplatin. The study also explores the effect of these metal complexes on the structural and kinetic properties involved in biological activity, as well as their interaction with DNA, enzymes, and proteins, which could contribute to their antitumor activity.